72-week results) 2 JAMA Network (2023)Tirzepatide (SURMOUNT) obesity trials: efficacy and safety data (~20% weight loss at 15 mg weekly) 3 The Lancet (2023)Tirzepatide in type 2 diabetes: Phase 2 trial (weight loss and glycemic outcomes at 36 weeks) 4 PubMed / NEJM (2023)Tirzepatide dosing and tolerability: starting at 2 mg vs 4 mg reduces GI adverse events 5 Metabolites (PMC, 2025)TirzepatideA Game Changer in Obesity Pharmacotherapy (comprehensive review of mechanism and trials) 6 New England Journal of Medicine (2022)Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1, NEJM 2022) 7 PubMed (2025)Meta-analysis: Tirzepatide achieves ~14% greater weight reduction vs placebo with no increase in adverse events 8 Molecular Metabolism (2025)Preclinical tri-agonist NN1706 (related compound): mechanism and pharmacokinetics 9 Nature Reviews Endocrinology (2024)Dual GIP/GLP-1 receptor agonists for obesity and diabetes: a clinical landscape review 10 Journal of Cachexia, Sarcopenia and Muscle (PMC)Protein requirements during weight loss: preserving lean mass 11 GenScriptPeptide Storage and Handling Guidelines (technical bulletin for lyophilized and reconstituted peptides) 12 BachemHandling and Storage Guidelines for Peptides (technical article on stability and freeze-thaw cycles) 13 Centers for Disease Control and Prevention (CDC)Vaccine Administration: Subcutaneous Injection (technique, angle, and site guidance) 14 NCBI BookshelfInjection Administration Best Practices (aseptic technique, sharps disposal, and safety) 15 Pharmacologic Considerations of the Subcutaneous Route (PMC)Subcutaneous injection technique and site rotation to prevent lipohypertrophy 16 Prime Lab PeptidesTirzepatide (10 mg) product page (quality documentation and specifications) Tirzepatide frequently asked questions How do I reconstitute a 10 mg vial of Tirzepatide
McCormick CM, Furey BF, Child M, Sawyer MJ, Donohue SM
You may be a strong candidate if you: Want better recovery or muscle repair Are dealing with stubborn belly fat Are dealing with stubborn beaStruggle with low energy or staminally fat Experience inflammation or chronic tendon/joint pain Want to enhance skin quality and collagen Are preparing for or recovering from surgery Want to optimize aging on a cellular level Are already on BHRT and want an additional performance/repair boost Wave will always consider your medical history, current medications, and hormone baseline before recommending peptides
Central hypocortisolism as part of combined pituitary hormone deficiency due to mutations of PROP-1 gene
The first infusion lasts five hours and is titrated starting at a low rate with an increase every half hour
Made from 16 gauge, cold rolled U.S
